Reuters US Business

By Rishav Chatterjee and Shivangi Lahiri (Reuters) -Star Entertainment’s planned 50% stake sale in its A$3.6 billion ($2.32 billion) Brisbane resort failed after its Hong Kong-based investors looking to exit the joint venture refused to extend talks, it said on Friday, sending its shares to a record low. The collapse of the Queen’s Wharf deal …

Star Entertainment’s Brisbane casino deal collapses; shares hit record low Read More »

By Katya Golubkova and Yuka Obayashi TOKYO (Reuters) -Nippon Steel revised on Friday its forecast for the full fiscal year to a 40 billion yen ($266 million) loss from 200 billion yen profit previously, mostly due to charges related to its acquisition of U.S. Steel. In June, Nippon Steel, Japan’s biggest steelmaker, closed its $14.9 …

Nippon Steel warns of annual loss due to charges related to US Steel acquisition Read More »

(Reuters) -Arthur J. Gallagher reported a rise in second-quarter profit on Thursday, supported by strong insurance spending that led to higher commissions and fees for the company. Insurance brokerages, which act as intermediaries by assisting customers in selecting suitable plans for their needs, do not directly sell policies. Insurance spending stayed strong in the quarter …

Arthur J. Gallagher’s quarterly profit rises on higher commissions and fees Read More »

By Prakhar Srivastava (Reuters) -Derivatives exchange Cboe Global Markets beat Wall Street estimates for second-quarter profit on Friday, as looming economic uncertainties fueled market turmoil and boosted options trading, sending its shares up more than 3%. A spike in volatility fueled by renewed geopolitical tensions in the Middle East and unpredictable tariff policies lifted trading …

Cboe tops profit estimates as market volatility boosts hedging activity Read More »

By Siddhi Mahatole (Reuters) -Regeneron topped Wall Street estimates for second-quarter results on Friday, on robust demand for its blockbuster eczema drug Dupixent, and said it does not expect a material impact from tariffs on imports from the European Union. Under the U.S.-EU trade deal announced earlier this week, all branded medicines will be subject …

Regeneron posts better-than-expected Q2 results, downplays tariff impact Read More »

(Corrects to remove reference to resumption of Novum pumps shipments in paragraph 4) By Kamal Choudhury (Reuters) -Baxter International slashed its 2025 profit forecast and posted disappointing quarterly earnings on Thursday, as lingering fallout from Hurricane Helene and continued hospital fluid conservation weighed on its medical products business. Shares of the medical products maker tumbled …

Medical products maker Baxter cuts 2025 forecast; shares plunge to 19-year low Read More »

By Niket Nishant and Alun John (Reuters) -Coinbase shares slumped 15% and hit their lowest in more than a month on Friday, after the crypto exchange reported a drop in second-quarter adjusted profit due to a slowdown in trading. The stock was last trading at $321.68, set to wipe out $14.3 billion of market value …

Coinbase shares sink after trading weakness hits quarterly profit Read More »

By Kritika Lamba and Rashika Singh (Reuters) -Reddit’s shares surged 15% on Friday after it reported quarterly results that exceeded Street expectations, boosting investor confidence in the platform’s AI-based advertising tools and strong user engagement. The company has also posted a rosy forecast that comes on the heels of similarly upbeat results from ad industry …

Reddit surges as AI-driven ad strategy wins praise from Wall Street Read More »